New experimental vaccine for Lou Gehrig's disease gets EU funding

4.6 (773) ·

$ 5.99 ·

In stock

Description

National_Institutes_of_Health

EU regulator accepts for review Alzheimer's treatment from Eisai

TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral

ALS patients contend with $158,000 price tag on new drug

RNA Drugs and RNA Targets for Small Molecules: Principles

New experimental vaccine for Lou Gehrig's disease gets EU funding

Stories: New EIC Transition project GA-VAX, with Intravacc and

When Dying Patients Want Unproven Drugs

New experimental vaccine for Lou Gehrig's disease gets EU funding

Spring 2021 by Penn Bioethics Journal - Issuu